RxDoctor Payments Data

Bhavi Shah

Adult Health · Oklahoma City, OKNPI 1437596442

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 24.5% of the total. Reporting peaked in 2023 at $261 and has fallen 65.2% since, to $91 in 2025. That places this record below the midpoint for adult health clinicians in OK, where the typical reported total is $570.

$637in general payments, 2019–2025

Across 15 payments — averaging $42.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$156
  • Amgen$121
  • Abiomed$120
  • Johnson & Johnson$114
  • Merck$23
  • Cashflow Solutions, LLC$21
  • plus $83 from 5 others

What the payments were for

  • Food & beverage$637100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$637 in reported general payments places this provider in the 50th percentile of 117 adult health providers in Oklahoma.

See all adult health providers in Oklahoma

Medicare billing

Part B allowed, 2024
$14,218
Medicare patients
86
Services billed
172

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban24$14,853
Carvedilol24$708
Atorvastatin Calcium38$421
Hydralazine Hcl19$346
Amlodipine Besylate36$227
Metoprolol Tartrate35$137
Chlorthalidone11$134
Ezetimibe27$127
Lisinopril20$127
Metoprolol Succinate12$78

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$15$14,85324 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 117 adult health providers in Oklahoma.

Other adult health in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →